These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34780972)

  • 1. Structural and functional characterization of the FimH adhesin of uropathogenic Escherichia coli and its novel applications.
    Foroogh N; Rezvan M; Ahmad K; Mahmood S
    Microb Pathog; 2021 Dec; 161(Pt B):105288. PubMed ID: 34780972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface display of uropathogenic Escherichia coli FimH in Lactococcus lactis: In vitro characterization of recombinant bacteria and its protectivity in animal model.
    Derakhshandeh S; Shahrokhi N; Khalaj V; Habibi M; Moazzezy N; Asadi Karam MR; Bouzari S
    Microb Pathog; 2020 Apr; 141():103974. PubMed ID: 31926238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and development of FimH lectin domain for rising immune response after injection by uropathogenic E. coli.
    Zandi M; Fallah Mehrabadi J; Mahdavi M; Irani S
    Hum Antibodies; 2020; 28(2):169-178. PubMed ID: 32116244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Analysis of Uropathogenic E.coli Isolates from Urinary Tract Infections.
    Valadbeigi H; Esmaeeli E; Ghafourian S; Maleki A; Sadeghifard N
    Infect Disord Drug Targets; 2019; 19(3):322-326. PubMed ID: 30421685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dimeric and Trimeric Fusion Proteins Generated with Fimbrial Adhesins of Uropathogenic
    Luna-Pineda VM; Reyes-Grajeda JP; Cruz-Córdova A; Saldaña-Ahuactzi Z; Ochoa SA; Maldonado-Bernal C; Cázares-Domínguez V; Moreno-Fierros L; Arellano-Galindo J; Hernández-Castro R; Xicohtencatl-Cortes J
    Front Cell Infect Microbiol; 2016; 6():135. PubMed ID: 27843814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive selection identifies an in vivo role for FimH during urinary tract infection in addition to mannose binding.
    Chen SL; Hung CS; Pinkner JS; Walker JN; Cusumano CK; Li Z; Bouckaert J; Gordon JI; Hultgren SJ
    Proc Natl Acad Sci U S A; 2009 Dec; 106(52):22439-44. PubMed ID: 20018753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vivo Consumption of Cranberry Exerts ex Vivo Antiadhesive Activity against FimH-Dominated Uropathogenic Escherichia coli: A Combined in Vivo, ex Vivo, and in Vitro Study of an Extract from Vaccinium macrocarpon.
    Rafsanjany N; Senker J; Brandt S; Dobrindt U; Hensel A
    J Agric Food Chem; 2015 Oct; 63(40):8804-18. PubMed ID: 26330108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients.
    Ghosh A; Mukherjee M
    Folia Microbiol (Praha); 2019 Jul; 64(4):587-600. PubMed ID: 30835050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential stability and trade-off effects of pathoadaptive mutations in the Escherichia coli FimH adhesin.
    Weissman SJ; Beskhlebnaya V; Chesnokova V; Chattopadhyay S; Stamm WE; Hooton TM; Sokurenko EV
    Infect Immun; 2007 Jul; 75(7):3548-55. PubMed ID: 17502398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a chimeric protein composed of FimH, FyuA and CNF-1 virulence factors from uropathogenic Escherichia coli and evaluation its biological activity and immunogenicity in vitro and in vivo.
    Hedayat S; Habibi M; Hosseini Doust R; Asadi Karam MR
    Microb Pathog; 2023 Jan; 174():105920. PubMed ID: 36460143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of fimH and iss type 1, 2 and 3 genes in uropathogenic Escherichia coli isolates recovered from an apex medical institute in North India.
    Bali N; Borkakoty B; Ali A; Ahmed T; Roohi S; Wani S; Nisar Q; Hazarika R
    Indian J Med Microbiol; 2023; 46():100417. PubMed ID: 37945109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uropathogenic virulence factor FimH facilitates binding of uteropathogenic Escherichia coli to canine endometrium.
    Krekeler N; Marenda MS; Browning GF; Holden KM; Charles JA; Wright PJ
    Comp Immunol Microbiol Infect Dis; 2012 Sep; 35(5):461-7. PubMed ID: 22554919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine profile in HTB-4 cells with respect to
    Koley S; Mukherjee M
    Future Microbiol; 2023 May; 18():489-503. PubMed ID: 37288968
    [No Abstract]   [Full Text] [Related]  

  • 15. Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations.
    Willner D; Low S; Steen JA; George N; Nimmo GR; Schembri MA; Hugenholtz P
    mBio; 2014 Feb; 5(2):e01064-13. PubMed ID: 24570371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs).
    Tartof SY; Solberg OD; Riley LW
    J Med Microbiol; 2007 Oct; 56(Pt 10):1363-1369. PubMed ID: 17893175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The affinity of the FimH fimbrial adhesin is receptor-driven and quasi-independent of Escherichia coli pathotypes.
    Bouckaert J; Mackenzie J; de Paz JL; Chipwaza B; Choudhury D; Zavialov A; Mannerstedt K; Anderson J; Piérard D; Wyns L; Seeberger PH; Oscarson S; De Greve H; Knight SD
    Mol Microbiol; 2006 Sep; 61(6):1556-68. PubMed ID: 16930149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular variations in Klebsiella pneumoniae and Escherichia coli FimH affect function and pathogenesis in the urinary tract.
    Rosen DA; Pinkner JS; Walker JN; Elam JS; Jones JM; Hultgren SJ
    Infect Immun; 2008 Jul; 76(7):3346-56. PubMed ID: 18474655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of a domain in the FimH adhesin of Escherichia coli type 1 fimbriae capable of receptor recognition and use of a domain-specific antibody to confer protection against experimental urinary tract infection.
    Thankavel K; Madison B; Ikeda T; Malaviya R; Shah AH; Arumugam PM; Abraham SN
    J Clin Invest; 1997 Sep; 100(5):1123-36. PubMed ID: 9276729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm formation by multidrug resistant Escherichia coli ST131 is dependent on type 1 fimbriae and assay conditions.
    Sarkar S; Vagenas D; Schembri MA; Totsika M
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26940589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.